SCHEMBL21934017

SCHEMBL21934017

c1ccc(-c2cc(-c3ccc(-c4cccc(-c5nc6ccccc6c6c(-c7ccccc7)cccc56)c4)cc3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
ALDH1A1 P00352 5/20 0.43
MAPT P10636 5/20 0.43
HPGD P15428 5/20 0.43
NTSR1 P30989 1/20 0.43
ACACA Q13085 3/20 0.42
KDM4E B2RXH2 5/20 0.42
LMNA P02545 3/20 0.42
ATM Q13315 1/20 0.42
GLA P06280 1/20 0.42
DHODH Q02127 1/20 0.41
ACHE P22303 1/20 0.39
MAOB P27338 2/20 0.38
MAOA P21397 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
MAPK1 P28482 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21934132 1.00 MEN1 (0.43) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21934843 1.00 MEN1 (0.43) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21934016 0.97 MEN1 (0.45) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21934710 0.97 MEN1 (0.43) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21934067 0.96 MEN1 (0.44) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21934626 0.96 MEN1 (0.44) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21934446 0.96 MEN1 (0.44) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21934093 0.95 ACACA (0.42) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21934104 0.95 MEN1 (0.47) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21934784 0.95 MEN1 (0.47) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200131133-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME HEESUNG MATERIAL LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131133-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 MEN1 343/4885KMT2A 794/4885ALDH1A1 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.